연구성과로 돌아가기

2024 연구성과별 연구자 정보 (1556 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
One-Dimensional Convolutional Neural Networks with Infrared Spectroscopy for Classifying the Origin of Printing Paper Kang, Kwang-Ho Kang, KH 4 교신저자 HP Printing Korea, 26 Yeonnaegaeul Ro, Seongnam Si 13105, Gyeonggi Do, South Korea kwangho.kang@hp.com;leewh@knu.ac.kr;
One-Dimensional Convolutional Neural Networks with Infrared Spectroscopy for Classifying the Origin of Printing Paper Lee, Won-Hee Lee, WH 5 교신저자 Kyungpook Natl Univ, Coll Agr & Life Sci, Dept Wood Sci & Technol, 80 Daehak Ro, Daegu 41566, South Korea kwangho.kang@hp.com;leewh@knu.ac.kr;
One-year Clinical Outcome of Topical Bromfenac in Central Serous Chorioretinopathy Kwon, Mi Sun Kwon, MS 1 Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, 130 Dongdeok, Daegu 41944, South Korea Dongho_Park@knu.ac.kr;
One-year Clinical Outcome of Topical Bromfenac in Central Serous Chorioretinopathy Kim, Yu Min Kim, YM 2 Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, 130 Dongdeok, Daegu 41944, South Korea Dongho_Park@knu.ac.kr;
One-year Clinical Outcome of Topical Bromfenac in Central Serous Chorioretinopathy Kim, Jin Young Kim, JY 3 Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, 130 Dongdeok, Daegu 41944, South Korea Dongho_Park@knu.ac.kr;
One-year Clinical Outcome of Topical Bromfenac in Central Serous Chorioretinopathy Do, Jae Rock Do, JR 4 Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, 130 Dongdeok, Daegu 41944, South Korea Dongho_Park@knu.ac.kr;
One-year Clinical Outcome of Topical Bromfenac in Central Serous Chorioretinopathy Kang, Yong Koo Kang, YK 5 Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, 130 Dongdeok, Daegu 41944, South Korea IVH-8723-2023 KANG, YONG KOO 0000-0002-6505-315X Kang, Yong Koo Dongho_Park@knu.ac.kr;
One-year Clinical Outcome of Topical Bromfenac in Central Serous Chorioretinopathy Park, Dong Ho Park, DH 6 교신저자 Kyungpook Natl Univ, Sch Med, Dept Ophthalmol, 130 Dongdeok, Daegu 41944, South Korea Dongho_Park@knu.ac.kr;
One-year Clinical Outcome of Topical Bromfenac in Central Serous Chorioretinopathy Park, Dong Ho Park, DH 6 교신저자 BK21 FOUR KNU Convergence Educ Program Biomed Sci, Daegu, South Korea Dongho_Park@knu.ac.kr;
One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study Bae, J. H. Bae, JH 1 Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Internal Med, Seoul, South Korea
One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study Park, J. B. Park, JB 2 Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Internal Med, Seoul, South Korea
One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study Baek, J. E. Baek, JE 3 Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol & Internal Med, Seoul, South Korea
One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study Lee, Y. J. Lee, YJ 4 Keimyung Univ, Sch Med, Dept Internal Med, Daegu, South Korea
One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study Lee, Y. J. Lee, YJ 4 CCAiD, Crohns & Colitis Assoc Daegu Gyeongbuk, Daegu, South Korea
One-year clinical outcomes of switching to subcutaneous infliximab in patients with inflammatory bowel disease on maintenance of intravenous infliximab therapy with or without remission: A multicentre cohort study Kim, K. O. Kim, KO 5 CCAiD, Crohns & Colitis Assoc Daegu Gyeongbuk, Daegu, South Korea
페이지 이동: